QUANTUMONLINE.COM SECURITY DESCRIPTION:  Chiron Real Estate Inc. 8.00% Series B Cumulative Redeemable Preferred Stock, liquidation preference $25 per share, redeemable at the issuer's option on or after 11/20/2030 at $25 per share plus accrued and unpaid dividends, and with no stated maturity. Cumulative distributions of 8.00% per annum ($2.00 per annum or $0.50 per quarter) will be paid quarterly on 1/31, 4/30, 7/31 & 10/31 to holders of record on the record date which will be 1/15, 4/15, 7/15 & 10/15 respectively (NOTE: the ex-dividend date is one business day prior to the record date). Upon the occurrence of a change of control the company will have the option within 120 days to redeem the preferred shares at $25 per share plus accrued and unpaid dividends. If the company has exercised their redemption right, the holders will NOT have the following conversion right. Upon the occurrence of a change of control, and the company has NOT provided notice that they intend to redeem the preferred shares, the holder will have the right to convert the preferred shares into common shares under certain circumstances (see the prospectus for details). Dividends paid by preferreds issued by REITs are NOT eligible for the preferential 15% to 20% tax rate on dividends and are also NOT eligible for the dividend received deduction for corporate holders. This security was not rated by Moody’s or S&P at the time of its IPO. In regard to the payment of dividends and upon liquidation, the preferred shares rank junior to the company's senior debt, equally with other preferreds of the company, and senior to the common shares of the company. See the IPO prospectus for further information on the preferred stock by clicking on the ‘Link to IPO Prospectus’ provided below.

Stock Exchange	Cpn Rate Ann Amt	LiqPref CallPrice	Call Date Matur Date	Moodys/S&P Dated	Distribution Dates	15% Tax Rate
NYSE Chart	8.00% $2	$25.00 $25.00	11/20/2030 None	NR NR 11/14/2025	1/31, 4/30, 7/31 & 10/31 Click for MW ExDiv Date Click for Yahoo ExDiv Date	No

Notes:  February 3, 2026 -- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to “Chiron Real Estate Inc.” Beginning on February 23, 2026, the Company’s common stock will trade on the New York Stock Exchange (the “NYSE”) under the new name, “Chiron Real Estate Inc.,” and ticker symbol “XRN.” “After spending the last six months evaluating and redefining our strategy, we are rebranding to better align with our new mission,” Mark Decker, Jr., Chief Executive Officer, said. “Chiron (Kai-ron), a figure from Greek mythology known for his knowledge and skill with medicine, was highly revered as a teacher and tutor and we believe Chiron embodies our refreshed mission: to deliver value at the intersection of care, capital and real estate, and our values of integrity and thought leadership.” The Company expects to publish an investor presentation outlining the Company’s 2026 strategic objectives alongside its fourth quarter earnings release. In connection with the name change, effective on February 23, 2026, the Company’s trading symbols on the NYSE will change from “GMRE” to “XRN” for the Company’s common stock, from “GMRE PrA” to “XRN PrA” for the Company’s Series A Preferred Stock, par value $0.001 per share, and from “GMRE PrB” to “XRN PrB” for the Company’s Series B Preferred Stock, par value $0.001 per share. The Company’s rebrand will affect the Company’s business operations through its passion to deliver value for all its stakeholders, but it will not affect some of the Company’s core components such as its organizational structure, stockholder rights or qualification as a REIT for U.S. federal income tax purposes. The Company’s outstanding securities will remain valid, and no action is required by securityholders because of the name or ticker changes. There will be no change to the Company’s CUSIP numbers in connection with the name and ticker symbol changes.

Company's Online Information Links

HOME PAGE:     https://www.globalmedicalreit.com/
Company's Investor Relations Information	Go to Investor Relations Information
Company's Online News Releases	Go to News Releases
Online Company Profile	Go to Online Profile

Company's Online SEC EDGAR Filings

Company's SEC EDGAR Filings

Go to SEC Filings

Company's Email Address Links

Email Address	investors@globalmedicalreit.com
Email Request Form on Website	Go to Email Form

Address and Phone Numbers

Address:   7373 Wisconsin Avenue, Suite 800,, Bethesda, MD 20814
Main Phone Number	202-524-6851
Fax Number	Not Available
Investor Relations   Evelyn Infurna, ICR Inc.	202-524-6869

CEO - Mark Decker, Jr.

CFO - Robert J. Kiernan